Immune checkpoint inhibitors for advanced pancreatic cancer
Publication date
2023-02-24
Authors
Chan, Wei Yen
Sim, Hao Wen
Abdi Haryono, Muhammad
Yip, Desmond
Chin, Venessa
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of immune checkpoint inhibitors (ICIs), as monotherapy or in combination (with chemotherapy or targeted therapy), for people with advanced pancreatic cancer compared with chemotherapy, targeted therapy, or placebo.
Keywords
Taverne, Pharmacology (medical)
Citation
Chan, W Y, Sim, H W, Abdi Haryono, M, Yip, D & Chin, V 2023, 'Immune checkpoint inhibitors for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, vol. 2023, no. 2, CD014523. https://doi.org/10.1002/14651858.CD014523